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Abstract
Background: Characteristics of COVID-19 patients have mainly been reported within confirmed COVID-19 cohorts.
By analyzing patients with respiratory infections in the emergency department during the first pandemic wave, we
aim to assess differences in the characteristics of COVID-19 vs. Non-COVID-19 patients. This is particularly important
regarding the second COVID-19 wave and the approaching influenza season.
Methods: We prospectively included 219 patients with suspected COVID-19 who received radiological imaging and
RT-PCR for SARS-CoV-2. Demographic, clinical and laboratory parameters as well as RT-PCR results were used for
subgroup analysis. Imaging data were reassessed using the following scoring system: 0 – not typical, 1 – possible,
2 – highly suspicious for COVID-19.
Results: COVID-19 was diagnosed in 72 (32,9%) patients. In three of them (4,2%) the initial RT-PCR was negative
while initial CT scan revealed pneumonic findings. 111 (50,7%) patients, 61 of them (55,0%) COVID-19 positive, had
evidence of pneumonia. Patients with COVID-19 pneumonia showed higher body temperature (37,7 ± 0,1 vs. 37,
1 ± 0,1 °C; p = 0.0001) and LDH values (386,3 ± 27,1 vs. 310,4 ± 17,5 U/l; p = 0.012) as well as lower leukocytes (7,6 ±
0,5 vs. 10,1 ± 0,6G/l; p = 0.0003) than patients with other pneumonia. Among abnormal CT findings in COVID-19
patients, 57 (93,4%) were evaluated as highly suspicious or possible for COVID-19. In patients with negative RT-PCR
and pneumonia, another third was evaluated as highly suspicious or possible for COVID-19 (14 out of 50; 28,0%).
The sensitivity in the detection of patients requiring isolation was higher with initial chest CT than with initial RT-
PCR (90,4% vs. 79,5%).
Conclusions: COVID-19 patients show typical clinical, laboratory and imaging parameters which enable a sensitive
detection of patients who demand isolation measures due to COVID-19.
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Computed tomography
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: nicola.fink@med.uni-muenchen.de
Fink, N and Rueckel, J shared first authorship
†Nicola Fink and Johannes Rueckel contributed equally to this work.
1Department of Radiology, University Hospital, LMU Munich, 81377 Munich,
Germany
2Comprehensive Pneumology Center (CPC-M), German Center for Lung
Research (DZL), 81377 Munich, Germany
Fink et al. BMC Infectious Diseases          (2021) 21:167 
https://doi.org/10.1186/s12879-021-05829-x
Background
In December 2019 an outbreak of a new coronavirus oc-
curred in Wuhan, China [1]. This virus was designated
as “Severe Acute Respiratory Syndrome Coronavirus 2”
(SARS-CoV-2) [2]. The associated disease was defined as
“coronavirus disease 19” (COVID-19) [3]. Within no
time SARS-CoV-2 spread across the globe and was fi-
nally declared a pandemic in March 2020 [4]. Within
Germany, Bavaria and especially Munich are among the
most severely and first affected regions.
COVID-19 usually manifests with symptoms of a re-
spiratory disease including, above all, fever and cough
[5–9]. Several studies have revealed typical laboratory
characteristics in COVID-19 patients, such as an in-
crease of C-reactive protein (CRP) and lactate dehydro-
genase (LDH) as well as leukocytopenia [5, 10, 11], and
typical findings in chest computed tomography (CT), in-
cluding bilateral, multilobar ground glass opacities and/
or consolidations especially in the peripheral lung zones
[12–16]. Currently, the most established method to de-
tect SARS-CoV-2 is the real-time reverse transcription
polymerase chain reaction (RT-PCR) [17, 18]. However,
several studies showed limitations of this testing method
regarding its sensitivity: While in some COVID-19 pa-
tients the initial RT-PCR was negative, the initial CT
scan already revealed typical findings [19, 20]. This sug-
gests a higher sensitivity of CT scans for the detection of
SARS-CoV-2. In addition, RT-PCR requires a long time
until results are available, whereas chest CT is per-
formed and assessed within a few minutes. In clinical
practice, prevailing conditions such as limited laboratory
capacities and high patient numbers can delay the re-
sults of RT-PCR, even though the analysis itself takes
only a few hours. The delay in decision-making on isola-
tion and appropriate treatment or in some cases even the
missing detection of COVID-19 due to low sensitivity of
RT-PCR ties up health care resources and implies a risk
with regard to the further spread of the virus. Thus, the
SARS-CoV-2 pandemic is also challenging radiological in-
stitutes. The analysis of COVID-19 typical clinical and
radiological characteristics is crucial in order to identify its
potential for efficient patient management. So far, most
studies analyzed cohorts including patients with con-
firmed COVID-19 [5–9, 11, 21]. Only a few studies com-
pared patients with and without COVID-19 in a cohort
with respiratory infections suspicious for COVID-19, but
mainly with a small sample size [13, 22, 23], with a low
rate of confirmed COVID-19 cases [24] or without ana-
lysis of radiological imaging [25]. Nevertheless, it is pre-
cisely this collective of cases with suspected COVID-19
that occurs in emergency departments during the pan-
demic and ties up health care resources to a large extent.
It is therefore crucial to analyze the characteristics of
COVID-19 patients in such a cohort in order to transfer
the results to everyday clinical practice in emergency
departments.
Therefore, this prospective and single-center study
aimed to define clinical and radiological characteristics
of COVID-19 patients within a cohort with respiratory
infections in the emergency department of one of Ger-
many’s largest university hospitals, situated in one of the
most affected regions in Germany. We hypothesize that
there are important differences between COVID-19
positive and negative patients with a respiratory infec-
tion regarding these characteristics. This may be a useful
adjunct to enable a sensitive and early detection of
COVID-19 in emergency departments, also with regard
to isolation of patients, which is mandatory to prevent
an ongoing viral spread but on the other hand ties up a
relevant proportion of healthcare capacities.
Methods
Patient population and data sources
We prospectively included 219 patients who were pre-
sented in the emergency department of the University
Hospital, LMU Munich, from March 16 to April
12 2020 with signs of a respiratory infection suspicious
for COVID-19 and received radiological imaging (chest
radiographs/CXR and / or CT) as well as RT-PCR for
SARS-CoV-2. Patients were defined as COVID-19 posi-
tive depending on the result of RT-PCR. The initial RT-
PCR was mainly done with samples of nasopharyngeal
and oropharyngeal swab as standard in the emergency
department. In the case of suspected COVID-19 despite
negative initial RT-PCR, analysis of lower respiratory
specimens such as endotracheal aspirate and bronchoal-
veolar lavage was performed in some cases (24 out of 57
patients with repeated testing despite initially negative
result; 42,1%). Patient age and gender were recorded in
all included patients, chronic comorbidities were add-
itionally registered in COVID-19 positive patients. Co-
morbidities were classified into the following groups:
respiratory, cardiovascular, oncological, neurological,
presence of diabetes mellitus and others. In case of ad-
mission, overall duration of hospitalization and intensive
care unit (ICU) stay was recorded. Furthermore, dur-
ation of symptoms, initial body temperature and relevant
initial laboratory values (CRP, leukocytes, interleukin-6/
IL-6 and LDH) at the time of presentation were re-
corded. Regarding IL-6 values, one outliner in the Non-
COVID-19 cohort with a value of 75,034 pg/ml (thresh-
old: ≤ 5,9 pg/ml) was excluded from the statistical
analysis.
Image acquisition
Radiological imaging of the chest included CXR and CT
scans at the time of presentation. CXRs were obtained in
upright or supine position at full inspiration. CT scans
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were performed as native high-resolution or contrast-
enhanced (in case of suspected pulmonal embolism) CT
scan (Somatom Force [Siemens Healthineers / Erlangen
/ Germany], Somatom Definition AS+ [Siemens Healthi-
neers / Erlangen / Germany] and Optima 660 [GE
Healthcare / Chalfont St Giles / Great Britain]).
Image interpretation / radiologist annotation
One board-certified radiologist as well as two radiology
residents (with 2 / 3 years of experience in thoracic im-
aging) evaluated the CXRs and CT scans by consensus
regarding pneumonic features and COVID-19 typical
findings. Readers were blinded to RT-PCR results as well
as clinical and laboratory data. In CXR images the pres-
ence of pneumonic features was rated using the follow-
ing scoring system: 0 – absent, 1 – possible and 2 –
present. CT scans were classified according to two dif-
ferent reading scores: 1) presence of pneumonic features
(0 – absent, 1 – present) and 2) presence of COVID-19
typical features (0 – not typical, 1 – possible, 2 – highly
suspicious). According to the current literature, COVID-
19 typical features were defined as ground glass opacities
(GGO) with or without “crazy paving” and/or consolida-
tions with peripheral emphasis [26]. In addition, pneu-
monic findings in CT scan were evaluated by
radiological readers per lung lobe regarding the presence
of ground glass opacities and/or consolidations.
Statistical analysis
Subgroups were defined based on the result of RT-PCR
for SARS-CoV-2 and the CT findings regarding the
presence pneumonic features. Comparison of those sub-
groups was done by Fisher’s exact test. Results were
graphically illustrated using the software GraphPad
Prism (Version 8.4.2, GraphPad, San Diego, California,
USA). Continuous variables were statistical analyzed
using Mann-Whitney U-Test. The sensitivity, specificity,
positive predictive value (PPV), negative predictive value
(NPV) and accuracy of initial RT-PCR and initial chest
CT for the detection of patients requiring isolation were
calculated using overall RT-PCR and CT scan in a sensi-
tive reading for COVID-19 (score 1 and 2) as reference.
Results
Study population and subgroup definition
In total, 219 patients with suspected COVID-19 due to
respiratory infection were presented at the emergency
department of our university hospital within 4 weeks
and received radiological imaging of the chest (CT or
CXR) as well as SARS-CoV-2 testing by RT-PCR. The
average age was 59.6 ± 1.3 (range: 19–99) years, gender
distribution 132 men and 87 women. 72 (32.9%) patients
were tested positive for SARS-CoV-2 by RT-PCR and
therefore defined as COVID-19 positive, 147 (67.1%)
were tested negative and defined as COVID-19 negative.
In the COVID-19 negative subgroup, 52 (35,4%) patients
were tested negative repeatedly, including 34 (23,1%)
with two, 16 (10,9%) with three, and two with four (2,
7%) negative tests for SARS-CoV-2. Among patients
with positive results, the initial test was negative in three
cases (4.2%), only further tests turned out to be positive:
one patient had COVID-19 confirmed by two tests, one
patient by three tests and one patient by four tests. In all
of them the initial CT scan showed pneumonic findings.
Figure 1 shows the CT scans of two of these patients in
whom the changes in initial chest CT were evaluated as
highly suspicious for COVID-19 despite initially negative
RT-PCR. Subgroups of COVID-19 positive and negative
patients did not significantly differ in age and gender
distribution. CT scan was performed in 189 patients.
Based on the result of RT-PCR and the presence of
pneumonic features in chest CT further subgroups were
defined (Fig. 2): 1) COVID-19 positive patients with
pneumonic findings (PCR +, CT +; 61 out of 189,
32.3%), 2) COVID-19 positive patients without pneu-
monic findings (PCR +, CT -; 8 out of 189, 4.2%), 3)
Fig. 1 Two COVID-19 patients with initially negative RT-PCR, but highly suspicious findings in initial CT scan. Patient A was tested positive for
COVID-19 in the second RT-PCR and patient B in the fourth, while initial CT scan already revealed typical findings
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COVID-19 negative patients with pneumonic findings
(PCR -, CT +; 50 out of 189, 26.5%), 4) COVID-19 nega-
tive patients without pneumonic findings (PCR -, CT -;
70 out of 189, 37.0%). Subgroups of patients with pneu-
monic features in CT scan did not significantly differ in
age and gender distribution.
In the course of the observed weeks at the beginning
of the pandemic in Germany, the number of patients
presenting themselves in the emergency department
with suspected COVID-19 and receiving radiological im-
aging showed the following changes (Fig. 3): An increase
in the number of patients and detected COVID-19 cases
was recorded between the first and the second week (in-
crease of 67.6% presenting patients and 92.3% of
COVID-19 cases). In the following weeks the number of
presenting patients remained at a similar level, the num-
ber of COVID-19 positive patients decreased (decrease
of 36.0% from week two to four).
A total of 174 patients were hospitalized (79.5%) with
a higher proportion among the COVID-19 positive pa-
tients (67 out of 72 patients, 93.1% vs. 72.8%; p =
0.0003). Among COVID-19 positive patients a total of
18 (26.9%) were admitted to an intensive care unit (ICU-
COVID-19 subgroup), on average 1.8 ± 0.6 days after
Fig. 2 Flowchart illustrating the composition of our study population and subgroups
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hospitalization. Those COVID-19 patients admitted to
an ICU had higher body temperature (38.2 ± 0.2 vs.
37.5 ± 0.1 °C; p = 0.011; threshold: ≤ 38 °C; Fig. 4) as well
as elevated levels of CRP (11.7 ± 2.0 vs. 5.0 ± 0.7 mg/dl;
p = 0.0003; threshold: ≤ 5 mg/dl; Fig. 4), LDH (468.7 ±
45.5 vs. 334.4 ± 27.9 U/l; p = 0.0004; threshold: ≤ 249 U/l;
Fig. 4) and IL-6 (237.1 ± 116.2 vs. 49.4 ± 12.6 pg/ml; p =
0.0002; threshold: ≤ 5.9 pg/ml; Fig. 4) than COVID-19
patients not admitted to an ICU (Non-ICU-COVID-19
subgroup). Leukocyte counts and D-dimer values did
not significantly differ between these subgroups (Fig. 4).
At the time of data collection, 146 patients could
already be discharged from hospital after a mean
hospitalization time of 8.6 ± 0.5 days with a longer
hospitalization of COVID-19 patients (10.4 ± 1.0 vs.
7.5 ± 0.5 days; p = 0.019). Three patients with confirmed
SARS-CoV-2 died (4.2%).
A detailed overview of patient outcome is given in
Table 1.
Clinical characteristics
The duration of symptoms at presentation in the emer-
gency department averaged 6.8 ± 6.3 days with a signifi-
cantly delayed presentation after onset of symptoms in
patients with COVID-19 (7.3 ± 0.7 vs. 6.6 ± 0.8 days; p =
0.01). In addition, body temperature was significantly
higher in patients with confirmed COVID-19 (37.7 ± 0.1
vs. 37.1 ± 0.1 °C; p < 0.0001; threshold: ≤ 38.0 °C; Fig. 5).
Fever, defined as a body temperature over 38 °C, was
more frequent in the COVID-19 subgroup than in the
Non-COVID-19 subgroup (40.0% vs. 15.0%, p = 0.0001).
However, in case of fever in COVID-19 patients, body
temperature was mainly just slightly above the threshold
of 38 °C with a mean body temperature of 38,6 ± 0,1 °C
in the respective group. Furthermore, patients with con-
firmed COVID-19 showed significantly higher values of
CRP (6.7 ± 0.8 vs. 4.7 ± 0.6 mg/dl, p = 0.003; threshold: ≤
5 mg/dl; Fig. 5) and LDH (370.0 ± 24.7 vs. 303.5 ± 18.6
U/l, p < 0.0001; threshold: ≤ 249 U/l; Fig. 5). At the same
time, leukocyte counts were significantly lower in the
COVID-19 subgroup: 7.4 ± 0.5 vs. 9.3 ± 0.3 G/l (p <
0.0001; threshold: female 4.0–10.4 G/l, male 3.9–9.8 G/l;
Fig. 5). Both groups did not significantly differ regarding
IL-6 and D-dimer values (Fig. 5).
When considering only patients with pneumonic fea-
tures in CT scan, the comparison between COVID-19
positive and negative patients confirmed by RT-PCR
showed the following results: Patients with COVID-19
pneumonia showed longer symptom duration at presen-
tation in the emergency department (7.3 ± 0.6 vs. 4.9 ±
0.8 days; p = 0.003) as well as significantly higher body
temperature (37.7 ± 0.1 vs. 37.1 ± 0.1 °C; p = 0.0001;
threshold: ≤ 38 °C) and LDH values (386.3 ± 27.1 vs.
310.4 ± 17.5 U/l; p = 0.012; threshold: ≤ 249 U/l) than pa-
tients with pneumonia due to other cause (Fig. 5). At
the same time, leukocyte counts were significantly lower
in patients with COVID-19 pneumonia (Fig. 5): 7.6 ± 0.5
vs. 10.1 ± 0.6 G/l; p = 0.0003 (threshold: female 4.0–10.4
G/l, male 3.9–9.8 G/l). Groups of COVID-19 positive
and negative patients with pneumonic features in CT
scan did not differ significantly regarding age, sex, CRP,
IL-6 and D-dimer values. The initial characteristics are
presented in detail in Table 2.
Radiological characteristics
Radiological imaging was performed in all patients: 30
(13.7%) patients only received CXR, 164 (74.9%) a thor-
acic CT scan and 25 (11.4%) both.
In CT examination 111 (58.7% of CT scans) patients
had evidence of abnormal findings compatible with
pneumonia, 61 (55.0%) of them were tested positive for
SARS-CoV-2 in RT-PCR. 50 (45.0%) patients showed
pneumonic findings due to another cause with a nega-
tive result in RT-PCR for SARS-CoV-2. In comparison,
bilateral pneumonia was more common (91.8% vs.
58.0%; p < 0.0001) and more lung lobes were affected
Fig. 3 Patients with suspected COVID-19 per week (16 March to 12 April 2020)
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(4.3 ± 0.1 vs. 2.6 ± 0.2; p < 0.0001) in COVID-19 patients
than in patients with pneumonia of other causes. There
were no significant differences in the presence of ground
glass opacities or consolidations between COVID-19
positive and negative patients with pneumonia.
Among COVID-19 patients with pneumonic fea-
tures (n = 61), the abnormal CT findings were evalu-
ated as highly suspicious for COVID-19 (score 2) in
45 (73.8%), as possible (score 1) in 12 (19.7%) and as
not typical for COVID-19 (score 0) in four patients
(6.6%). At the same time, in patients without COVID-
19 the radiological readers defined the pneumonic
findings in chest CT as not typical (score 0) in 36 pa-
tients (72.0%), as possible (score 1) in 13 (26.0%) and
as highly suspicious for COVID-19 (score 2) in one
case (2.0%). A total of 78 (41.3% of CT scans) pa-
tients showed no pneumatic features in chest CT, 8
(10.3%) of them with positive and 70 (89.7%) with
negative RT-PCR for SARS-CoV-2.
Among patients with confirmed COVID-19 by RT-
PCR and findings highly suspicious for COVID-19 (score
2) in chest CT, there were ten patients who also received
CXR on the same day as CT scan. In all of them the ab-
normal CT findings due to COVID-19 pneumonia were
also detected (n = 8, score 2) or at least suspected (n = 2,
score 1) in CXR.
A detailed overview of initial radiological imaging fea-
tures is illustrated in Table 2.
Performance of RT-PCR and chest CT in detecting patients
requiring sensitive isolation
Among the patients with a RT-PCR and CT scan (n =
189), 83 (43.9%) required a sensitive isolation due to an
overall positive result in RT-PCR and/or a positive result
for COVID-19 in a sensitive CT reading (score 1 and 2).
The sensitivity in the detection of these patients was
79.5% (95% CI 69.6–86.8%) with initial RT-PCR and
90.4% (95% CI 82.1–95.0%) with initial Chest CT. The
Fig. 4 Body temperature and laboratory values compared between ICU and Non-ICU subgroup within confirmed COVID-19 patients. “PCR +”
includes COVID-19 patients confirmed by RT-PCR. * p < 0.05; ** p < 0.01; *** p < 0.001; ns = not significant
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test performances of RT-PCR and chest CT are reported
in Table 3.
Discussion
In the present study we analyzed clinical and diag-
nostic features including laboratory parameters and
radiological imaging features in 219 patients who
were presented in the emergency department of our
university hospital with signs of a respiratory infec-
tion suspicious for COVID-19 within the first
4 weeks the coronavirus pandemic reached our
hospital.
Table 1 Clinical outcome of our study cohort
Characteristics
n (%) if not labelled differently
COVID-19 positive* COVID-19 negative* p-value
Total
(n = 72)









Hospitalization 67 (93.1) 60 (98.4) 107 (72.8) 45 (90.0) 0.0003 0.089
Duration of hospitalization in days**
(mean ± SEM)
10.4 ± 1.0 11.3 ± 1.1 7.5 ± 0.5 9.8 ± 1.0 0.019 0.404
Admission to ICU 18 (26.9) 18 (30.0) 15 (14.0) 12 (26.7) 0.047 0.828
Hospitalization to ICU in days
(mean ± SEM)
1.8 ± 0.6 1.8 ± 0.6 1.7 ± 0.8 1.9 ± 0.9 0.474 0.500
Duration of intensive care in days**
(mean ± SEM)
10.6 ± 2.3 10.6 ± 2.3 7.3 ± 1.5 8.0 ± 1.6 0.367 0.550
Outcome
Discharged 53 (79.1) 46 (76.7) 93 (86.9) 37 (82.2)
Still hospitalized*** 11 (16.4) 11 (18.3) 11 (10.3) 6 (13.3)
Dead 3 (4.5) 3 (5.0) 3 (2.8) 2 (4.4)
No hospitalization 5 (6.9) 1 (1.6) 40 (27.2) 5 (10.0)
*based on the result in RT-PCR for SARS-CoV-2; **number of patients for whom the values were available; **in patients who are already discharged from hospital
or at least intensive care unit (ICU); ***on April 27 2020
Fig. 5 Body temperature and laboratory values: 1) COVID-19 positive vs. negative, 2) COVID-19 pneumonia vs. other pneumonia. “PCR +” includes
COVID-19 patients confirmed by RT-PCR. “PCR -“ includes patients with a negative result for SARS-CoV-2 in RT-PCR. “CT +” includes patients with
pneumonic findings in chest CT. * p < 0.05; ** p < 0.01; *** p < 0.001; ns = not significant
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Table 2 Demographic, clinical and diagnostic characteristics at initial presentation of our study cohort
Diagnostic features
n (%) if not labelled differently
COVID-19 positivea COVID-19 negativea p-value
Total (n = 72) With pneumonia
in CT (n = 61)
Total (n = 147) With pneumonia
in CT (n = 50)
Total With
Pneumonia
Age in years (mean ± SEM) 60.0 ± 2.0 63.1 ± 2.0 59.5 ± 1.7 61.7 ± 2.9 0.955 0.903
Sex 0.141 0.534
Male 49 (68.1) 45 (73.8) 83 (56.5) 34 (68.0)
Female 23 (31.9) 16 (26.2) 64 (43.5) 16 (32.0)
Comorbidities in COVID-19 patients
Total (≥1 system) 52 (72.2) 46 (75.4)
Respiratory 10 (13.9) 32 (52.4)
Cardiovascular 35 (48.6) 9 (14.8)
Oncological 7 (9.7) 7 (11.5)
Neurological 8 (11.1) 7 (11.5)
Diabetes 11 (15.3) 10 (16.4)
Others 32 (44.4) 28 (45.9)
Duration of symptoms at presentation
in days (mean ± SEM)
7.3 ± 0.7 (n = 52)** 7.3 ± 0.6 (n = 45)** 6.6 ± 0.8 (n = 85)** 4.9 ± 0.8 (n = 29)** 0.010 0.003
Body temperature at presentation
in °C (mean ± SEM)
37.7 ± 0.1 (n = 65)** 37.7 ± 0.1 (n= 57)** 37.1 ± 0.1 (n = 140)** 37.1 ± 0.1 (n = 48)** < 0.0001 0.0001


























































Positive 72 (100.0) 61 (100.0) – –
By initial test 69 (95.8) 58 (95.1) – –
Several tests necessary for
detection
3 (4.2) 3 (4.9)
By second test 1 (1.4) 1 (1.6) – –
By third test 1 (1.4) 1 (1.6) – –
By fourth test 1 (1.4) 1 (1.6) – –
Negative – – 147 (100.0) 50 (100.0)
Radiological imaging at presentation
CXR 15 (20.8) 11 (18.0) 36 (24.5) 7 (14.0)
Pneumonic features
Present (score 2) 8 (53.3) 8 (72.7) 6 (16.7) 4 (57.1)
Possible (score 1) 3 (20.0) 2 (18.2) 7 (19.4) 3 (42.9)
Absent (score 0) 4 (26.7) 1 (9.1) 23 (63.9) 0 (0.0)
Chest CT 69 (95.8) 61 (100.0) 120 (81.6) 50 (100.0)
Pneumonic features
Unilateral 5 (8.2) 21 (42.0) < 0.0001
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The development of patient numbers showed a strong
increase in suspected cases and COVID-19 positive pa-
tients especially within the first 2 weeks (increase by 67.6
and 92.3%, respectively). While in the following weeks the
suspected cases remained at a largely stable but still high
level, the number of confirmed COVID-19 patients de-
creased by over a third. This shows the positive effects of
containment measures, but also reveals a nevertheless
challenging number of patients for whom optimal man-
agement is crucial. In everyday clinical practice, efficient
strategies must therefore be developed to sensitively detect
COVID-19 patients among the high number of suspicious
cases, using available resources efficiently. Typical charac-
teristics of COVID-19 patients can be helpful in an effort
to cope with the limited health care capacities as effi-
ciently as possible. It has already been shown that
COVID-19 patients have typical characteristics regarding
clinical symptoms, laboratory values and radiological find-
ings. However, these studies mainly analyzed patients with
confirmed COVID-19 [5–9, 11, 21]. Only a few studies an-
alyzed a cohort of suspected COVID-19 cases as done in
our study, but then mostly with a significantly smaller
sample size [13, 22, 23] (21 to 38 patients versus 219 in
the present study), with a smaller proportion of COVID-
19 patients [24] (5% versus 32.9% in the present study) or
without analysis of radiological aspects [25]. Thus, our
study scrutinizes a patient cohort that has rarely been in-
vestigated so far. However, it is particularly this evaluation
of a cohort of suspicious cases that allows us to draw con-
clusions about the clinical setting in emergency
departments affected by the COVID-19 pandemic and to
demonstrate the potential of typical characteristics of
COVID-19 patients compared to patients affected by
other respiratory infections for optimal patient
management.
Our study was able to identify certain features that
were dominant in COVID-19 patients when juxtaposing
both groups: Patients with confirmed COVID-19 were
more likely to have fever and showed significantly higher
values of CRP and LDH. At the same time, leukocyte
counts were significantly lower in COVID-19 patients
than in patients with respiratory symptoms not caused
by COVID-19. Even by correlating laboratory parame-
ters and findings in chest CT concerning pneumonia,
our study showed that patients with pneumonia caused
by COVID-19 had higher body temperature and LDH
values as well as lower leukocyte counts than patients
with pneumonia of other origin. This may be a useful
adjunct when making a decision regarding the likelihood
of COVID-19 infection in cases of disputed abnormal
CT findings.
The benefit of comparing those characteristics within
a cohort of patients with suspected COVID-19 is also
shown by the fact that the results differ when comparing
subgroups within confirmed COVID-19 patients. While
in the cohort with suspected COVID-19 IL-6 values did
not significantly differ between COVID-19 positive and
negative patients regardless of the presence of pneumo-
nia, it was precisely this value within the ICU-COVID-
19 and Non-ICU-COVID-19 subgroup that was of high
Table 2 Demographic, clinical and diagnostic characteristics at initial presentation of our study cohort (Continued)
Diagnostic features
n (%) if not labelled differently
COVID-19 positivea COVID-19 negativea p-value
Total (n = 72) With pneumonia
in CT (n = 61)
Total (n = 147) With pneumonia
in CT (n = 50)
Total With
Pneumonia
Bilateral 56 (91.8) 29 (58.0) < 0.0001
Affected lung lobes (mean ± SEM) 4.3 ± 0.1 2.6 ± 0.2 < 0.0001
Presence of GGOs 61 (100.0) 48 (96.0) 0.201
Presence of Consolidations 38 (62.3) 35 (70.0) 0.427
COVID-19 features
Typical (score 2) 45 (65.2) 45 (73.8) 1 (0.8) 1 (2.0)
Possible (score 1) 12 (17.4) 12 (19.7) 13 (10.8) 13 (26.0)
Not typical (score 0) 12 (17.4) 4 (6.6) 106 (88.3) 36 (72.0)
abased on the result in RT-PCR for SARS-CoV-2
Table 3 Performance of initial RT-PCR and CT in detecting patients who require isolation
Results (n) Test performance (%)
TP TN FP FN Sensitivity [95% CI] Specificity [95% CI] PPV [95% CI] NPV [95% CI] Accuracy [95% CI]




















TP true positive, TN true negative, FP false positive, FN false negative, PPV positive predictive value, NPV negative predictive value, CI confidence interval.
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significance: COVID-19 patients admitted to an ICU had
significantly higher IL-6 values than COVID-19 patients
without intensive care treatment. This suggests that IL-6
values may indicate disease severity in COVID-19 pa-
tients – as already shown by Herold et al. [27] – but do
not allow any conclusion to be drawn about the possibil-
ity of COVID-19 infection as a cause of respiratory
symptoms. At the same time, leukocyte counts did not
significantly differ between ICU-COVID-19 and Non-
ICU-COVID-19 subgroup, while this value was particu-
larly relevant between the COVID-19 positive and nega-
tive subgroups within patients with respiratory
infections. This discrepancy between the different sub-
groups suggests that transferring the results in cohorts
with confirmed COVID-19 - as they have mainly been
analyzed so far - to cohorts with suspected COVID-19
and thus to everyday clinical setting in emergency de-
partments is not possible.
Currently, hospitalization and isolation as well as fur-
ther management of patients is mainly dependent on the
results of RT-PCR. Nevertheless, several studies have
already demonstrated a lack of sensitivity of RT-PCR
[19, 20] and identified CT as an important tool in diag-
nosing COVID-19. In our study COVID-19 pneumonia
differed from pneumonia of other cause only in the ex-
tent of the pneumonic features (affecting both lungs and
more lobes), but not in the presence of ground glass
opacities and consolidations. However, in almost all RT-
PCR-positive COVID-19 patients with pneumonic fea-
tures in CT scan, radiological readers classified those
findings as highly suspicious (score 2) or at least possible
(score 1) for COVID-19 (57 out of 61; 93.4%). At the
same time, in patients with negative RT-PCR and yet
pneumonic features in CT scan, these CT findings were
evaluated as not typical for COVID-19 (score 0) in most
cases (36 out of 50; 72.0%). Thus, COVID-19 could also
be detected or excluded with high probability using only
CT scan. Nevertheless, in almost one third of those pa-
tients with evidence of pneumonia on chest CT but
negative RT-PCR for SARS-CoV-2, the abnormal find-
ings were assessed as highly suspicious (score 2) or pos-
sible (score 1) for COVID-19 (14 out of 50; 28%). The
fact that also in COVID-19 patients confirmed by RT-
PCR abnormal CT findings were classified as possible
for COVID-19 (score 1) in 19.7% (12 out of 61), shows
that CT findings require a sensitive assessment. Even
such “possible” COVID-19 cases suspected by CT scan
have to be listed as potentially infectious despite negative
RT-PCR, at least until further tests provide certainty
about the COVID-19 status. In our study, the sensitivity
in the detection of patients requiring isolation was
higher with initial chest CT than with initial RT-PCR
(90.4% vs. 79.5%). Thus, chest CT offers a sensitive se-
lection of patients requiring isolation, monitoring and
therapy due to COVID-19, also with an additional detec-
tion of possible COVID-19 in almost one third of RT-
PCR-negative patients. Even if COVID-19 had been de-
tected by CT scan alone, in case of pneumonic features
only 6.6% (4 out of 61) of the patients who actually were
diagnosed with COVID-19, determined by RT-PCR,
would not have been caught. Therefore, this could also
open up possibilities in regions with limited availability
of RT-PCR in order to still offer the best possible patient
care. Overall, these results suggest that the combination
of RT-PCR, clinical and laboratory characteristics as well
as chest CT has the potential to provide optimal patient
management. In case of doubt, especially in presence of
typical symptoms, a supplementary CT scan should be
performed even in cases with negative RT-PCR. Espe-
cially since our study showed that in 4.2% of patients
who have been tested positive overall, the initial RT-
PCR showed a negative result, while initial CT scan yet
showed pneumonic features in all of them. Only a high
sensitivity in diagnosing and isolating COVID-19 pa-
tients can prevent a further spread in hospitals among
staff and other sick, partly immunocompromised and
thus particularly vulnerable patients.
Among COVID-19 patients who received CXR and
chest CT, the pneumonic CT features could also be de-
tected or at least suspected in CXR in all ten cases.
Therefore, CXR could be a helpful tool, especially in
countries and hospitals with limited access to CT scans
or RT-PCR. Furthermore, the possibility of detecting
COVID-19 pneumonia in CXR can play a major role in
COVID-19 patients’ follow-up: In case of an already de-
tected COVID-19 infection, opacities can be monitored
by portable CXR in order to save CT resources and pre-
vent contamination and spread due to transport of
COVID-19 patients across the hospital [28].
Our study has several limitations such as an ongoing
hospitalization of some patients at the time of the sub-
mission. Furthermore, the investigated cohort mainly in-
cludes patients with a moderate or severe disease or
with a high risk for a severe course due to the internal
procedure for radiological imaging in patients with sus-
pected COVID-19. This is also shown by the fact that
almost all COVID-19 patients were hospitalized, and a
comparatively high proportion required intensive care
treatment.
Conclusion
In conclusion, our study showed that despite successful
containment measures, the number of suspected
COVID-19 cases remains challenging. In comparison
with respiratory infections of other causes, COVID-19
patients present certain characteristics regarding clinical
symptoms and laboratory values, which can be a useful
adjunct in making decisions in a number of cases, even
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in the assessment of unclear findings in CT scans. Fur-
thermore, the performance of CT scans in patients with
respiratory infections suspicious for COVID-19 enables
a sensitive selection of those requiring isolation, moni-
toring and treatment due to COVID-19. Thus, in every-
day clinical practice, the combination of RT-PCR, typical
clinical and laboratory characteristics as well as thoracic
CT is a helpful tool for improved containment and pa-
tient management in emergency departments.
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